ATE522529T1 - Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst - Google Patents

Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst

Info

Publication number
ATE522529T1
ATE522529T1 AT07803228T AT07803228T ATE522529T1 AT E522529 T1 ATE522529 T1 AT E522529T1 AT 07803228 T AT07803228 T AT 07803228T AT 07803228 T AT07803228 T AT 07803228T AT E522529 T1 ATE522529 T1 AT E522529T1
Authority
AT
Austria
Prior art keywords
enamine
pyridoä2
racemat
cleavage
producing
Prior art date
Application number
AT07803228T
Other languages
English (en)
Inventor
Stefan Abrecht
Jean-Michel Adam
Alec Fettes
Stefan Hildbrand
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE522529T1 publication Critical patent/ATE522529T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/31—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07803228T 2006-09-15 2007-09-05 Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst ATE522529T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06120722 2006-09-15
PCT/EP2007/059264 WO2008031749A1 (en) 2006-09-15 2007-09-05 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine

Publications (1)

Publication Number Publication Date
ATE522529T1 true ATE522529T1 (de) 2011-09-15

Family

ID=38779613

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07803228T ATE522529T1 (de) 2006-09-15 2007-09-05 Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst

Country Status (8)

Country Link
US (4) US20080071087A1 (de)
EP (1) EP2066667B1 (de)
JP (1) JP5235018B2 (de)
CN (1) CN101516880B (de)
AT (1) ATE522529T1 (de)
CA (1) CA2662413C (de)
ES (1) ES2371369T3 (de)
WO (1) WO2008031749A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090938A1 (es) 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) 2008-08-15 2019-12-18 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
TWI466672B (zh) 2009-01-29 2015-01-01 Boehringer Ingelheim Int 小兒科病人糖尿病之治療
PL2395983T3 (pl) 2009-02-13 2020-09-07 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna zawierająca inhibitor sglt2, inhibitor dpp-iv i ewentualnie dalszy środek przeciwcukrzycowy oraz jej zastosowania
NZ619520A (en) 2009-02-13 2015-06-26 Boehringer Ingelheim Int Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
NZ599298A (en) 2009-11-27 2014-11-28 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
EP2547339A1 (de) 2010-03-18 2013-01-23 Boehringer Ingelheim International GmbH Kombination eines gpr119-agonisten und des dpp-iv-hemmers linagliptin zur verwendung bei der behandlung von diabetes und zugehöriger erkrankungen
WO2011138421A1 (en) 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
EP2599769A4 (de) * 2010-07-28 2015-05-20 Sumitomo Chemical Co Verfahren zur herstellung eines carboxylsäureamids
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9227901B2 (en) 2012-07-05 2016-01-05 Abbvie Inc. Process for preparing bicyclic amine derivatives
WO2014152768A1 (en) * 2013-03-15 2014-09-25 Portola Pharmaceuticals, Inc. Cyclohexanediamine compounds and methods for their preparation
JP6253564B2 (ja) * 2014-11-13 2017-12-27 日本電信電話株式会社 画像符号化装置，画像復号装置，画像符号化方法，画像復号方法，画像符号化プログラムおよび画像復号プログラム
CN111632400B (zh) * 2020-06-21 2022-04-05 赤峰制药股份有限公司 一种烯胺盐重结晶纯化方法
CN115197137B (zh) * 2022-07-07 2024-04-02 中国科学院成都生物研究所 异喹啉酮类化合物及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727261B2 (en) * 2001-12-27 2004-04-27 Hoffman-La Roche Inc. Pyrido[2,1-A]Isoquinoline derivatives
BRPI0411713B8 (pt) * 2003-06-20 2021-05-25 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
BRPI0411509A (pt) * 2003-06-20 2006-07-25 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização

Also Published As

Publication number Publication date
CN101516880B (zh) 2012-06-20
US20130338366A1 (en) 2013-12-19
ES2371369T3 (es) 2011-12-30
CA2662413C (en) 2015-08-25
CA2662413A1 (en) 2008-03-20
JP2010503634A (ja) 2010-02-04
US20130018191A1 (en) 2013-01-17
EP2066667A1 (de) 2009-06-10
EP2066667B1 (de) 2011-08-31
JP5235018B2 (ja) 2013-07-10
US20120022260A1 (en) 2012-01-26
WO2008031749A1 (en) 2008-03-20
CN101516880A (zh) 2009-08-26
US20080071087A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
ATE553083T1 (de) Verfahren zur herstellung eines 2- pyridylethylcarbonsäureamidderivats
ATE444295T1 (de) Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
MXPA05007516A (es) Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos.
PE20091403A1 (es) Derivados de carboxamidas n-azabiciclicas y su preparacion
WO2008031750A3 (en) Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine
ECSP088971A (es) Ligandos 101 de los receptores nicotínicos de acetilcolina
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
ATE490956T1 (de) Verfahren zur herstellung eines 2- ethylaminopyridinderivats
WO2007088276A3 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
DE50104600D1 (de) 8,8a-dihydro-indeno [1,2-d]thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika
ATE458476T1 (de) Verfahren für die zubereitung der amorphen form eines medikamentes
DE60236171D1 (de) Verfahren for zur herstellung eines 14-hydroxynormorphinon-derivats
BRPI0612475B8 (pt) métodos para a preparação de um composto
EP1420028A3 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
ATE295368T1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
DE60224257D1 (de) Retinolderivate und verfahren zu deren herstellung
NZ588252A (en) Process for the preparation of donepezil hydrochloride
DE60234279D1 (de) Verfahren zur herstellung eines immunosuppresivums
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
ATE424390T1 (de) Verfahren zur herstellung von delmopinol und derivaten davon
ATE489367T1 (de) Verfahren und zwischenprodukt zur herstellung von donezepil
DE602004021654D1 (de) Verfahren zur Herstellung eines martensitischen Stahles ohne Schmelzen
ATE478040T1 (de) Verfahren zur herstellung von kontrastmitteln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties